Immunology Market Expected To Grow At A CAGR Of 8.45% By 2025 | Overview of emerging trends, opportunities and new product launches

0

NEW YORK, November 29, 2021 / PRNewswire / – The “Immunology Market – Competitive Analysis, Drivers, Challenges, and Five Forces Analysis“has been added to Technavio’s offering. The immunology market is expected to grow by $ 55.00 billion from 2020 to 2025, with a CAGR of 8.45% according to Technavio’s latest report.

Attractive Opportunities in Immunology Market by Category and Geography – Forecast and Analysis 2021-2025

For more information on the Immunology Market – Download a free sample now!

40% of market growth will come from North America. The United States is a key market for immunology in the region. The increasing cases of infectious diseases will facilitate the growth of the immunology market in North America. The report offers up-to-date analysis of the market geography, competitive intelligence, and regional in-store opportunities for vendors.

Market dynamics
Factors such as growing organ transplant will be crucial to stimulate market growth. However, entry of biosimilars will limit market growth. Holistic engine analysis will help predict end goals and refine marketing strategies to gain competitive advantage.

Company Profiles
The immunology market is fragmented and vendors deploy various organic and inorganic growth strategies to compete in the market. The Immunology Market report provides comprehensive information of major vendors including AbbVie Inc., Amgen Inc., Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., Johnson and Johnson Inc., Novartis AG, Pfizer Inc., Sumitomo Dainippon Pharma Co. Ltd., Takeda Pharmaceutical Co. Ltd. and UCB SA.

Few companies with key offers

  • AbbVie Inc. – The company offers immunology products namely HUMIRA.

  • Amgen Inc. – The company offers immunology products namely IMLYGIC.

  • Bristol-Myers Squibb Co – The company offers immunology products namely ORENCIA.

Competitive analysis
The competitive scenario provided in the Immunology market report analyzes, assesses, and positions the companies based on various performance indicators. Some of the factors considered for this analysis include the financial performance of companies in recent years, growth strategies, product innovations, new product launches, investments, market share growth, etc.

Market segmentation

  • By category, the market is categorized into Immunosuppressants and Immunostimulants. Growth in the market share of immunology by the immunosuppressant segment was important.

  • By geography, the market is classified as North America, Europe, Asia, and RANG. North America will have the largest market share.

Related reports –
Biotechnology Reagents Market –The biotechnology reagents market size is expected to reach a value of USD 32.11 billion, at a CAGR of 7.39%, during 2021-2025. Download a free sample now!

Cell Viability Testing Market –The size of the cell viability testing market has the potential to grow by $ 1.40 billion during the period 2020-2024, and the growth dynamics of the market will accelerate during the forecast period. Download a free sample now!

Scope of Immunology Market

Cover of the report

Details

Page number

120

Year of reference

2020

Forecast period

2021-2025

Growth dynamics and CAGR

Accelerate to a CAGR of 8.45%

Market growth 2021-2025

$ 55.00 billion

Market structure

Fragmented

Annual growth (%)

8.01

Regional analysis

North America, Europe, Asia and ROW

Efficient contribution to the market

North America at 40%

Main consumer countries

United States, Germany, United Kingdom, China and Japan

Competitive landscape

Leading companies, competitive strategies, reach of consumer engagement

Profiled companies

AbbVie Inc., Amgen Inc., Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., Johnson and Johnson Inc., Novartis AG, Pfizer Inc., Sumitomo Dainippon Pharma Co. Ltd., Takeda Pharmaceutical Co. Ltd . ., and UCB SA

Market dynamics

Parent Market Analysis, Market Growth Drivers and Obstacles, Analysis of Fast Growing and Slow Growing Segments, Impact of COVID-19 and Future Consumer Dynamics, Analysis of Market Conditions for the Forecast Period

Customization

If our report didn’t include the data you’re looking for, you can reach out to our analysts and customize the segments.

About Us
Technavio is one of the world’s leading technology research and consulting companies. Their research and analysis focuses on emerging market trends and provides actionable insights to help companies identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialist analysts, Technavio’s report library includes over 17,000+ reports, spanning 800 technologies, spanning 50 countries. Their customer base consists of companies of all sizes, including more than 100 Fortune 500 companies. This growing customer base relies on Technavio’s comprehensive coverage, in-depth research and actionable market intelligence to identify opportunities in existing markets. and potentials and assess their competitive positions in changing market scenarios.

Contact
Technavio research
Jesse maida
Communication and Marketing Officer
United States: +1 844 364 1100
UK: +44 203 893 3200
E-mail: [email protected]
Website: www.technavio.com/

Technavio (PRNewsfoto / Technavio)

Technavio (PRNewsfoto / Technavio)

Cision

Cision

View original content to download multimedia: https://www.prnewswire.com/news-releases/immunology-market-to-grow-at-a-cagr-of-8-45-by-2025insights-on-emerging -trends -opportunités – new-product-launches-17000-technavio-reports-301432366.html

SOURCE Technavio


Source link

Share.

Comments are closed.